Natus to Present at Jefferies 2017 Healthcare Conference
May 30, 2017 11:04 am UTC| Business
PLEASANTON, Calif., May 30, 2017 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that Jim Hawkins, President and Chief Executive Officer, will present at the Jefferies 2017 Healthcare Conference in New York...
Natus to Present at Jefferies 2017 Healthcare Conference
May 30, 2017 11:04 am UTC| Business
PLEASANTON, Calif., May 30, 2017 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that Jim Hawkins, President and Chief Executive Officer, will present at the Jefferies 2017 Healthcare Conference in New York...
Natus to Present at Jefferies 2017 Healthcare Conference
May 30, 2017 11:04 am UTC| Business
PLEASANTON, Calif., May 30, 2017 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that Jim Hawkins, President and Chief Executive Officer, will present at the Jefferies 2017 Healthcare Conference in New York...
Natus to Present at Jefferies 2017 Healthcare Conference
May 30, 2017 11:04 am UTC| Business
PLEASANTON, Calif., May 30, 2017 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that Jim Hawkins, President and Chief Executive Officer, will present at the Jefferies 2017 Healthcare Conference in New York...
NeuroDerm CEO to Present at the Jefferies Global Healthcare Conference on June 7, 2017
May 30, 2017 11:04 am UTC| Business
REHOVOT, Israel, May 30, 2017 -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, today announced that CEO Oded S....
NeuroDerm CEO to Present at the Jefferies Global Healthcare Conference on June 7, 2017
May 30, 2017 11:04 am UTC| Business
REHOVOT, Israel, May 30, 2017 -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, today announced that CEO Oded S....
NeuroDerm CEO to Present at the Jefferies Global Healthcare Conference on June 7, 2017
May 30, 2017 11:04 am UTC| Business
REHOVOT, Israel, May 30, 2017 -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, today announced that CEO Oded S....